Women With Epilepsy Suffer Greater Seizure Frequency During Anovulatory Cycle

A recent multi-center study determined that women with generalized tonic-clonic seizures (GTCS) had a greater number of seizures during anovulatory cycles - menstrual cycles where an egg is not released - than in cycles where ovulation occurs…

Structural Factors Integral To Understanding Girls’ Vulnerability To HIV In Sub-Saharan Africa

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health shows that community members correlate an increase in HIV vulnerability among adolescent girls with weak structural support systems…

Chronic NSAID Use Doubles CV Deaths in Elderly

Older patients with CAD and hypertension should avoid using NSAIDs for pain, where possible, suggests a new analysis of the INVEST study. Heartwire

New Guidelines for Genetic Testing in Alzheimer’s Disease

Although testing for genetic susceptibility is not recommended, tests for causative genes should be offered when appropriate. Medscape Medical News

FDA Panel Endorses Novel Drug for Lymphoma

WASHINGTON (MedPage Today) — An FDA advisory panel has voted unanimously to recommend accelerated approval for brentuximab vedotin (Adcetris) to treat Hodgkin lymphoma in patients who have already had a stem cell transplant, and for patients with relapsed or resistant systemic anaplastic large cell lymphoma.

When Medicaid Paid Better, Kids Had More Dental Visits (CME/CE)

(MedPage Today) — When dentists were reimbursed more for preventive visits, kids on Medicaid ended up in their chairs more often, likely because the increased compensation made them more willing to accept those patients, a government researcher said.

Racial Disparity Link to Pressure Ulcer Rates Studied (CME/CE)

(MedPage Today) — Residents of nursing homes with the highest percentage of black residents were more likely to have pressure ulcers than those in homes with the lowest proportion of black residents, researchers found.

Michael J. Fox Foundation awards Impax $400,000 grant for research of IPX066 for Parkinson’s disease

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., has been awarded funding of up to $400,000 by The Michael J. Fox Foundation for ongoing clinical research of the Company’s investigational carbidopa-levodopa extended release (CD-LD ER) product IPX066, which is intended to treat the motor symptoms of Parkinson’s disease (PD).

Positive data from Inovio’s VGX-3400X Phase I study against H5N1 influenza

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.

Eisai’s DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.